Novo Nordisk | Eigenkapital Und Reserven



Equity Capital And Reserves Veränderung Datum
ANI Pharmaceuticals USD 403.68M 2.27M 2024-12
Aurora Cannabis CAD 572.92M 29.75M 2024-12
Bausch Health Companies USD -1183000000 861M 2025-03
Bristol-Myers Squibb USD 17.39B 1.05B 2025-03
Canopy Growth CAD 591.48M 81.81M 2024-12
Corcept Therapeutics USD 679.59M 40.75M 2024-12
Drreddys Laboratories INR 317.72B 12.38B 2024-12
Eli Lilly USD 15.85B 1.65B 2025-03
GlaxoSmithKline GBP 14.16B 486M 2025-03
Merck USD 48.34B 2.02B 2025-03
Novartis USD 44.05B 605M 2024-12
Novo Nordisk 138.54B 18.02B 2025-03
Novo Nordisk DKK 120.52B 8B 2024-09
Pacira USD 778.35M 28.76M 2024-12
Perrigo USD 4.36B 44.6M 2025-03
Prestige Brands USD 1.79B 56.67M 2024-12
Sanofi 74.07B 3.78B 2025-03
Supernus Pharmaceuticals USD 1.04B 28.58M 2024-12
Zoetis USD 4.66B 115M 2025-03



Novo Nordisk Eigenkapital Und Reserven - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.